ACET
Adicet Bio, Inc.
Latest Form 4:Purchase$525KbyRA CAPITAL MANAGEMENT, L.P. (10% Owner) · filed Apr 13, 2026
Adicet Bio, Inc. (ACET) has 8 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 29, 2026.
The most active filer is 10% Owner RA CAPITAL MANAGEMENT, L.P. with 3 filings. Insiders have net bought $929K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Chen Schor
- Employees:102
- HQ:Boston, MA, US
- IPO:2018-01-26
Insider Buying
$6.6M
reported purchases (SEC code P)
Insider Selling
$675K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Related companies
Adicet Bio, Inc. is in the Healthcare sector.